Ackman defends Valeant, hints at more changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Valeant Pharma (VRX) Continues Push Higher
May 3, 2016 12:44 PM EDTValeant Pharma (NYSE: VRX) is pushing to the highs of the session following positive credit rating agency comments on a default, strong results from peer Mallinckrodt, short covering and as Joe Papa officially assumes the reigns.
Shares are up 9.85% to $35.87.
... MoreGeneral Growth Properties (GGP) Declares $0.19 Quarterly Dividend; 2.7% Yield
May 3, 2016 8:50 AM EDTGeneral Growth Properties (NYSE: GGP) declared a quarterly dividend of $0.19 per share, or $0.76 annualized.
The dividend will be payable on July 29, 2016, to stockholders of record on July 15, 2016, with an ex-dividend date of July 13, 2016.
The annual yield on the dividend is 2.7... More
Valeant Pharma (VRX) Says Joseph Papa Officially Assumes Role of Chairman, CEO
May 3, 2016 7:15 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that Joseph C. Papa has assumed the role of Chairman and Chief Executive Officer. As previously announced, Joseph C. Papa succeeds J. Michael Pearson.
"I am thrilled to begin working closely with the talented... More
Valeant Pharma (VRX) may change its name at some point - Bill Ackman
May 2, 2016 12:43 PM EDTValeant Pharma (NYSE: VRX) may change its name at some point - Bill Ackman
... More